Below are the three companies in the Biotechnology industry with the lowest price to earnings to growth (PEG) ratios. PEG is valuable in assessing the tradeoff between the price of a stock and expected growth. Generally, the lower the PEG, the better.
Alkermes (NASDAQ:ALKS) is lowest with a PEG ratio of 0.25. Alkermes, Inc. develops products based on drug delivery technologies. The Company is focusing on controlled, sustained release of injectable drugs, as well as the delivery of drugs into the brain past the blood-brain barrier. Alkermes is also focusing on the oral delivery of drugs, and the development of pharmaceutical products based on pulmonary drug delivery technologies.
Alkermes has overhead space with shares priced $30.53, or 1.5% below the average consensus analyst price target of $31.00. Alkermes shares have support at the 50-day moving average (MA) of $29.42 and additional support at the 200-day MA of $22.66.
United Therapeutics (NASDAQ:UTHR) is next with a PEG ratio of 0.46.
Finishing up the bottom three is Anika Therapeutics (NASDAQ:ANIK), with a PEG ratio of 0.74.